Molecular Partners Aktie
| 4,63CHF | 0,37CHF | 8,69% |
WKN DE: A12DEH / ISIN: CH0256379097
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 89,49 |
| BVF Partners LP | 21,14 |
| Suvretta Capital Management LLC | 10,62 |
| Novartis AG | 4,31 |
| Patrick Amstutz, PhD | 4,00 |
| EcoR1 Capital, LLC | 2,69 |
| Hansjörg Wyss | 2,67 |
| Michael Tobias Stumpp, PhD | 1,90 |
| GAM Swiss Sustainable Companies | 1,27 |
| UBAM - Swiss Equity | 0,90 |
| GAM Multistock - Swiss Small & Mid Cap Equity | 0,72 |
| UBS (CH) Equity Fund - Switzerland Sustainable (CHF) | 0,68 |
| UBS (CH) Equity Fund - Small Caps Switzerland (CHF) | 0,59 |
| Andreas Emmenegger, EMBA | 0,59 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 147 | 159 | 177 | 191 | 182 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,14 | 0,06 | 0,06 | 0,99 | 0,04 |
Bilanz (in Mio. CHF) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 100 | 178 | 164 | 255 | 192 |
| Summe Anlagevermögen | 5 | 10 | 8 | 8 | 6 |
| Summe Aktiva | 105 | 188 | 173 | 262 | 198 |
Bilanz (in Mio. CHF) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 51 | 80 | 65 | 27 | 22 |
| Summe Eigenkapital | 54 | 107 | 107 | 235 | 176 |
| Summe Passiva | 105 | 188 | 173 | 262 | 198 |
Adresse
| Wagistrasse 14, 8952 Schlieren | |
| Telefon | +41 (44) 755-77-00 |
| Fax | +41 (44) 755-77-07 |
| Internet | http://www.molecularpartners.com |
Management
|
Agnete Brunsvik Fredriksen
Independent Director |
|
Alexander Zürcher
Chief Operating Officer |
|
Anne Goubier
Senior VP-Research & Early Development |
|
Baris Arican
Vice President-Information Technology |
|
Daniel Steiner
Senior Vice President-Research & Technology |
|
Dominik Höchli
Independent Director |
|
Michael J. Vasconcelles
Independent Non-Executive Director |
|
Michael Pitzner
SVP-Legal, General Counsel & Compliance Officer |
|
Michael Tobias Stumpp
Executive Vice President-Projects |
|
Patrick Amstutz
Chief Executive Officer & Director |
|
Philippe Legenne
Chief Medical Officer |
|
Renate Gloggner
Executive VP-People, Community & Culture |
|
Robert Hendriks
Senior Vice President-Finance |
|
Sandipkumar S. Kapadia
Independent Director |
|
Seth D. Lewis
SVP-Investor Relations, Communications & Strategy |
|
Steven H. Holtzman
Independent Non-Executive Director |
|
Vito J Palombella
Independent Director |
|
William Matt Burns
Chairman |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
